Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Alkermes plc logo

Alkermes plc

Sector: Healthcare   

Industry: Biotechnology

24.50
 
USD
  
-0.31
  
(-1.25%)
Optionable: Yes  Market Cap: 4,195 M  90-day average vol: 1,769,482

Previous close: 24.81  Open: 24.54  Bid: 24.15  Ask: 25.4
52 week range    
22.01   
   33.71
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

ALKS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles58 M58 M61 M62 M65 M40 M39 M38 M36 M36 M
Basic EPS from continuing operations-1.25-0.7-0.3-0.973.12
Basic EPS total-0.21-1.52-1.25-0.7-0.3-0.972.14
Basic weighted shares outstanding145 M149 M151 M153 M155 M157 M159 M161 M164 M166 M
BasicDiscontinuousOperations-0.98
Cost of sales-176 M-139 M-132 M-155 M-176 M180 M178 M197 M218 M253 M
Depreciation-40 M-28 M-33 M-36 M-38 M40 M42 M41 M26 M26 M
Depreciation unreconciled58 M58 M61 M62 M65 M40 M39 M38 M36 M36 M
DepreciationAndAmortization58 M58 M61 M62 M65 M40 M39 M38 M36 M36 M
Diluted EPS total-0.21-1.52-1.38-1.03-0.9-1.25-0.7-0.3-0.972.1
Diluted normalized net income/share-0.973.06
Diluted weighted shares outstanding145 M149 M151 M153 M155 M157 M159 M161 M164 M170 M
DilutedDiscontinuousOperations-0.96
GainOnSaleOfPPE40 M
GainOnSaleOfSecurity15 M10 M
GainsLossOnDisposalOfDiscontinuedOperations-136 M-165 M
GeneralAndAdministrativeExpense-6 M-7 M-8 M-9 M-11 M599 M539 M561 M591 M690 M
Gross operating profit443 M489 M614 M749 M918 M991 M860 M976 M894 M1,410 M
Income before tax-14 M-224 M-214 M-143 M-127 M-197 M-97 M-39 M-31 M422 M
Income restructuring and M&A-220000.013 M6 M
Income taxes16 M3 M-6 M15 M12 M-436000.014 M9 M2 M-98 M
Interest income73 M6 M4 M5 M9 M14 M7 M2 M8 M31 M
InterestExpenseNonOperating13 M13 M15 M12 M15 M14 M9 M11 M13 M23 M
MiscOtherSpecialCharges-2 M15000.0-2 M-10 M-2 M848000.014 M219000.02 M-425000.0
Net income from total operations-30 M-227 M-208 M-158 M-139 M-197 M-111 M-48 M-158 M356 M
NetIncomeCommonStockholders-30 M-227 M-208 M-158 M-139 M-197 M-111 M-48 M-158 M356 M
NetIncomeContinuousOperations-30 M-227 M-208 M-158 M-139 M-197 M-111 M-48 M-158 M356 M
NetIncomeDiscontinuousOperations-136 M-165 M
NetNonOperatingInterestIncomeExpense60 M-7 M-11 M-7 M-6 M375000.0-2 M-9 M-5 M8 M
Normalized income330 M
Operating income-87 M-224 M-209 M-148 M-99 M-175 M-112 M-29 M-6 M414 M
Operating income before depreciation (EBITDA)97 M-125 M-105 M-33 M-8 M-103 M-6 M51 M60 M519 M
OperatingExpense530 M714 M822 M897 M1,017 M1,153 M973 M1,006 M900 M996 M
Other income net-13 M-7 M-5 M-12 M22 M22 M-18 M1 M20 M425000.0
OtherGainLossFromDispositionOfDiscontinuedOperations-125 M-163 M
OtherGandA-6 M-7 M-8 M-9 M-11 M599 M539 M561 M591 M690 M
OtherImpairmentOfCapitalAssets-10 M-6 M
OtherOperatingExpenses-1 M-1 M-917000.0-877000.0-559000.0-738000.0-796000.0-731000.0-590000.0-558000.0
PromotionAndAdvertising-9 M-11 M-24 M-34 M-55 M31 M26 M39 M41 M128 M
RentAndLandingFees-6 M-7 M-8 M-9 M-11 M
Research & development expense272 M344 M387 M413 M425 M513 M395 M407 M273 M271 M
ResearchExpense272 M344 M387 M413 M425 M513 M395 M407 M273 M271 M
RestructringAndMnAIncome-220000.013 M6 M
Revenue per share58 M58 M61 M62 M65 M40 M39 M38 M36 M36 M
SalariesAndWages-60 M-97 M-94 M-84 M-105 M2 M3 M2 M3 M3 M
Selling Gen & administrative expense200 M312 M374 M422 M526 M599 M539 M561 M591 M690 M
SellingAndMarketingExpense200 M312 M374 M422 M526 M31 M26 M39 M41 M128 M
SellingExpense200 M312 M374 M422 M526 M
Special income/charges220000.0-13 M-6 M
Total Income available for interest expense (EBIT)-599000.0-211 M-199 M-131 M-112 M-183 M-88 M-28 M-18 M445 M
Total common shares outstanding148 M151 M153 M156 M156 M158 M159 M162 M164 M167 M
Total net income-30 M-227 M-208 M-158 M-139 M-197 M-111 M-48 M-158 M356 M
Total ordinary shares169 M169 M169 M169 M169 M169 M169 M169 M169 M169 M
Total revenues619 M628 M746 M903 M1,094 M1,171 M1,039 M1,174 M1,112 M1,663 M
TotalExpenses354 M575 M690 M742 M841 M1,333 M1,151 M1,203 M1,118 M1,249 M
TotalRevenue94 M149 M256 M903 M1,094 M1,171 M1,039 M1,174 M1,112 M1,663 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University